222 related articles for article (PubMed ID: 8095852)
41. Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma.
Evertsson S; Bartik Z; Zhang H; Jansson A; Sun XF
Int J Oncol; 1999 Jul; 15(1):53-8. PubMed ID: 10375593
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
[TBL] [Abstract][Full Text] [Related]
43. Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.
Kakeji Y; Maehara Y; Adachi Y; Baba H; Mori M; Furusawa M; Sugimachi K
Br J Cancer; 1994 Apr; 69(4):749-53. PubMed ID: 7908217
[TBL] [Abstract][Full Text] [Related]
44. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
[TBL] [Abstract][Full Text] [Related]
45. Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma.
Skopelitou A; Korkolopoulou P; Papanikolaou A; Hadjiyannakis M
J Cancer Res Clin Oncol; 1993; 119(7):379-81. PubMed ID: 8098331
[TBL] [Abstract][Full Text] [Related]
46. Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer.
Kovac D; Rubinic M; Krasevic M; Krizanac S; Petrovecki M; Stimac D; Melato M
Anticancer Res; 1995; 15(5B):2301-2. PubMed ID: 8572642
[TBL] [Abstract][Full Text] [Related]
47. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
Wu X; Zhang Z; Cai S
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
[TBL] [Abstract][Full Text] [Related]
48. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.
Tanaka S; Haruma K; Tatsuta S; Hiraga Y; Teixeira CR; Shimamoto F; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(2):134-9. PubMed ID: 7854773
[TBL] [Abstract][Full Text] [Related]
49. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
Fontanini G; Macchiarini P; Pepe S; Ruggiero A; Hardin M; Bigini D; Vignati S; Pingitore R; Angeletti CA
Cancer; 1992 Sep; 70(6):1520-7. PubMed ID: 1355398
[TBL] [Abstract][Full Text] [Related]
50. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer.
Yonemura Y; Fonseca L; Tsugawa K; Ninomiya I; Matsumoto H; Sugiyama K; Ohoyama S; Fushida S; Kimura H; Miyazaki I
Oncology; 1994; 51(3):251-7. PubMed ID: 7910957
[TBL] [Abstract][Full Text] [Related]
51. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
[TBL] [Abstract][Full Text] [Related]
52. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
53. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
54. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
55. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases.
Karameris A; Kanavaros P; Aninos D; Gorgoulis V; Mikou G; Rokas T; Niotis M; Kalogeropoulos N
Pathol Res Pract; 1993 Mar; 189(2):133-7. PubMed ID: 8321742
[TBL] [Abstract][Full Text] [Related]
56. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry.
Linden MD; Ma CK; Kubus J; Brown RD; Zarbo RJ
Am J Clin Pathol; 1993 Sep; 100(3):206-12. PubMed ID: 8104388
[TBL] [Abstract][Full Text] [Related]
57. Correlation of p53 expression and proliferative activity in gastric cancer.
Yonemura Y; Fushida S; Tsugawa K; Ninomiya I; Fonseca L; Yamaguchi A; Miyazaki I; Urano T; Shiku H
Anal Cell Pathol; 1993 Sep; 5(5):277-88. PubMed ID: 8105878
[TBL] [Abstract][Full Text] [Related]
58. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
59. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
60. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
